Perspectives in gene therapy

Histology and Histopathology

Volumn 13, Issue 1, 1998, Pages 231-242

  Ramon y Cajal S ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Gene therapy; Non viral vectors; Vital vectors

Indexed keywords

CATION; COMPLEMENTARY DNA; LIPOFECTIN; LIPOSOME; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; CANCER THERAPY; CYSTIC FIBROSIS; GENE THERAPY; HEMATOLOGIC DISEASE; HUMAN; LIVER DISEASE; NONHUMAN; PARVOVIRUS; PICORNAVIRUS; POXVIRUS; RETROVIRUS; REVIEW; TOGAVIRUS;

ANIMALS; DNA VIRUSES; GENE THERAPY; GENETIC VECTORS; HUMANS; RNA VIRUSES;

ADENOVIRIDAE; PARVOVIRUS; PICORNAVIRIDAE; POXVIRIDAE; TOGAVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0031963265     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Anderson D.C., Smith C.W. and Springer T.A. (1989). Leukocyte adhesion deficiency and other disorders of leukocyte motility. In: The metabolic basis of inherited disease. Scriver C.R., Beaudet A.L., Sly W.S. and Valle D.M. (eds). Mc Graw-Hill International Book Co. New York, pp 2751-2777.
2. Anderson W.F. (1992). Human gene therapy. Science 256, 808-813.
3. Avery O.T, Mc Leod and McCarty M. (1994). Studies on the chemical nature of the substance inducing transformation of pneumococcal types. J. Exp. Med. 79, 137-158.
4. Barranger J.A. and Ginns E.I. (1989). Glucosylceramide lipidoses. Gaucher disease. In: The metabolic basis of inherited disease. Scriver C.R., Beaudet A.L., Sly W.S. and Valle D.M. (eds). Me Graw-Hill International Book Co. New York, pp 1677-1698.
5. Berdenbeek P.J. and Rice C.M. (1992). Animal RNA virus expression systems: Semin. Virol. 3, 297-310.
6. Berglund P., Tubulekas I. and Liljeström P. (1996). Alphaviruses as vectors for gene delivery. TIBTECH 14, 130-134.
7. Blau H.M. and Springer M.L. (1995). Gene therapy - a novel form of drug delivery. New Engl. J. Med. 333, 1204-1207.
8. Bordignon C. (1993). Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID. Hum. Gene Ther. 4, 513-520.
9. Bos J.L. (1989). Ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
10. Buller R.M., Chakrabarti S., Cooper J.A., Twardzik D.R. and Moss B. (1988). Delection of the vaccinia virus growth factor gene reduces virus virulence. J. Virol. 62, 866-874.
11. Clemens P.R. and Caskey C.T. (1992). Duchenne muscular dystrophy. In: Current neurology. Appel S. (ed). Mosby-Year Book. St Louis. pp 1-22.
12. Colledge W.H., Ratcliff R., Foster D., Williamson R. and Evans M.J. (1992). Cystic fibrosis mouse with intestinal obstruction. Lancet 340, 680.